Best Overall Response [clinicaltrials_resource:NCT00191854/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Best Overall Response [clinicaltrials_resource:NCT00191854/outcome/1]
Bio2RDF identifier
NCT00191854/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00191854/outcome/1
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
Number of all randomized participants.
Number of randomized patients. ...... Gemcitabine + Cisplatin = 28.
Number of randomized patients. ...... Gemcitabine + Cisplatin = 22.
Number of randomized patients. ...... Gemcitabine + Cisplatin = 30.
Randomized patients who had ei ...... Gemcitabine + Cisplatin = 14.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
baseline to date of death from any cause (up to 34 months)
baseline to measured progressi ...... 24 months after randomization)
baseline to measured progressi ...... 24 months after randomization)
randomization to date of docum ...... ccurred first (up to 6 months)
time of response to progressiv ...... 24 months after randomization)
type [clinicaltrials_vocabulary:type]
alternate
Best Overall Response
@en
identifier
clinicaltrials_resource:NCT00191854/outcome/1
title
Response using Response Evalua ...... at do not meet above criteria.
@en
type
label
Best Overall Response [clinicaltrials_resource:NCT00191854/outcome/1]
@en